EUVIMEDEUVIMED entdecken
Crossref

Integrating Synergistic Mutagenesis and Targeted Metabolic Engineering with Process Control for the Hyper-Production of Pyrroloquinoline Quinone in Hyphomicrobium denitrificans

Jingnan Wang, Wenjing Zhu, Youtong Shen, Weixu Ma, Feng Guo, Zhen Gao, Yujia Jiang, Wankui Jiang, Fengxue Xin, Wenming Zhang, Min Jiang

ACS Synthetic Biology · 10.11.2026

DOI: 10.1021/acssynbio.6c00810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 10.11.2026. Verfasst von Jingnan Wang und 10 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Jiangsu Province Young Scientific and Technological Talents Promotion Plan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pyrroloquinoline quinone (PQQ), a redox-active quinone cofactor with diverse physiological functions, has attracted increasing attention owing to its expanding applications in pharmaceuticals, agriculture, and electrochemical sensing. Microbial fermentation provides a sustainable and scalable approach for PQQ production. In this study, an elite mutant strain, WX17A, was obtained through combined mutagenesis and adaptive laboratory evolution. To further improve PQQ biosynthesis, key fermentation conditions were systematically optimized, and response surface methodology was subsequently employed to optimize the supplementation of exogenous amino acids, metal ions, and hydrogen peroxide. Targeted metabolic engineering further identified PqqC and PqqE as key engineering targets in the PQQ biosynthetic pathway. Rational overexpression of these genes increased the PQQ titer to 134.77 mg/L. Finally, a fed-batch fermentation strategy coupled with two-stage regulation of pH and dissolved oxygen was established in a 5 L bioreactor, resulting in a final PQQ titer of 385.83 mg/L. Overall, the integration of strain improvement, fermentation optimization, metabolic engineering, and process control substantially enhanced PQQ production, providing a promising basis for the development of efficient and scalable PQQ biomanufacturing.

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Jiangsu Province Young Scientific and Technological Talents Promotion Plan
  • State Key Laboratory of Materials-Oriented Chemical Engineering
  • Special Science and Technology Innovation Program for Carbon Peak and Carbon Neutralization of Jiangsu Province
  • Jiangsu Basic Research Center for Synthetic Biology
  • Jiangsu Province Major Innovation Platform Programme

Zitieren

APA

Wang, J., Zhu, W., Shen, Y., Ma, W., Guo, F., Gao, Z., Jiang, Y., Jiang, W., Xin, F., Zhang, W., & Jiang, M. (2026). Integrating Synergistic Mutagenesis and Targeted Metabolic Engineering with Process Control for the Hyper-Production of Pyrroloquinoline Quinone in Hyphomicrobium denitrificans. ACS Synthetic Biology. https://doi.org/10.1021/acssynbio.6c00810

Vancouver

Wang J, Zhu W, Shen Y, Ma W, Guo F, Gao Z, et al. Integrating Synergistic Mutagenesis and Targeted Metabolic Engineering with Process Control for the Hyper-Production of Pyrroloquinoline Quinone in Hyphomicrobium denitrificans. ACS Synthetic Biology. 2026. doi:10.1021/acssynbio.6c00810

BibTeX
@article{Wang2026,
  author = {Wang, Jingnan and Zhu, Wenjing and Shen, Youtong and Ma, Weixu and Guo, Feng and Gao, Zhen and Jiang, Yujia and Jiang, Wankui and Xin, Fengxue and Zhang, Wenming and Jiang, Min},
  title = {Integrating Synergistic Mutagenesis and Targeted Metabolic Engineering with Process Control for the Hyper-Production of Pyrroloquinoline Quinone in Hyphomicrobium denitrificans},
  journal = {ACS Synthetic Biology},
  year = {2026},
  doi = {10.1021/acssynbio.6c00810}
}
Kostenlos starten →